These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 7752089)

  • 1. Paradoxical blockade of beta adrenergically mediated inhibition of stimulated eosinophil secretion by salmeterol.
    Muñoz NM; Rabe KF; Vita AJ; McAllister K; Mayer D; Weiss M; Leff AR
    J Pharmacol Exp Ther; 1995 May; 273(2):850-4. PubMed ID: 7752089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta adrenergic modulation of formyl-methionine-leucine-phenylalanine-stimulated secretion of eosinophil peroxidase and leukotriene C4.
    Munoz NM; Vita AJ; Neeley SP; McAllister K; Spaethe SM; White SR; Leff AR
    J Pharmacol Exp Ther; 1994 Jan; 268(1):139-43. PubMed ID: 8301549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of enantiomeric forms of albuterol on stimulated secretion of granular protein from human eosinophils.
    Leff AR; Herrnreiter A; Naclerio RM; Baroody FM; Handley DA; Muñoz NM
    Pulm Pharmacol Ther; 1997; 10(2):97-104. PubMed ID: 9425641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of salbutamol and salmeterol on human eosinophil responses.
    Ezeamuzie CI; al-Hage M
    J Pharmacol Exp Ther; 1998 Jan; 284(1):25-31. PubMed ID: 9435156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of stimulated eosinophil degranulation by VLA-4 (CD49d)-mediated adhesion to fibronectin.
    Neeley SP; Hamann KJ; Dowling TL; McAllister KT; White SR; Leff AR
    Am J Respir Cell Mol Biol; 1994 Aug; 11(2):206-13. PubMed ID: 8049081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of LTC4 synthesis caused by additive inhibition of gIV-PLA2 phosphorylation: Effect of salmeterol and PDE4 inhibition in human eosinophils.
    Meliton AY; Muñoz NM; Liu J; Lambertino AT; Boetticher E; Myo S; Myou S; Zhu X; Johnson M; Leff AR
    J Allergy Clin Immunol; 2003 Aug; 112(2):404-10. PubMed ID: 12897749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of salmeterol on human eosinophils is both stimulus- and response-dependent.
    Ezeamuzie CI; al-Hage M; Nwankwoala RN
    Int J Immunopharmacol; 1997 Aug; 19(8):421-30. PubMed ID: 9568547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of (R)- and (S)-isomers of beta-adrenergic agonists on eosinophil response to interleukin-5.
    Volcheck GW; Kelkar P; Bartemes KR; Gleich GJ; Kita H
    Clin Exp Allergy; 2005 Oct; 35(10):1341-6. PubMed ID: 16238794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of human eosinophil respiratory burst and cyclic AMP hydrolysis by inhibitors of type IV phosphodiesterase: interaction with the beta adrenoceptor agonist albuterol.
    Dent G; Giembycz MA; Evans PM; Rabe KF; Barnes PJ
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1167-74. PubMed ID: 7996422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of salmeterol and nimesulide on chemotaxis and synthesis of PAF and LTC4 by human eosinophils.
    Tool AT; Mul FP; Knol EF; Verhoeven AJ; Roos D
    Eur Respir J Suppl; 1996 Aug; 22():141s-145s. PubMed ID: 8871060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desensitization of beta2-adrenoceptor and hypersensitization to phosphodiesterase inhibitors elicited by beta2-agonists in guinea pig eosinophils.
    Mio M; Kirino Y; Kamei C
    J Allergy Clin Immunol; 2000 Nov; 106(5):896-903. PubMed ID: 11080712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibitory effect of AS-35. a novel antiallergic drug, on chemical mediator release from human eosinophils].
    Kawashima T; Nagaki S; Iwakaji A; Iwamoto I; Yoshida S; Tomioka H
    Arerugi; 1994 Dec; 43(11):1326-30. PubMed ID: 7887808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-2 activates human peripheral blood eosinophils.
    Hoenstein R; Admon D; Solomon A; Norris A; Moqbel R; Levi-Schaffer F
    Cell Immunol; 2001 Jun; 210(2):116-24. PubMed ID: 11520078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The duration of action of non-beta 2-adrenoceptor mediated responses to salmeterol.
    Nials AT; Coleman RA; Johnson M; Vardey CJ
    Br J Pharmacol; 1997 Mar; 120(5):961-7. PubMed ID: 9138705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjunctival fibroblasts enhance the survival and functional activity of peripheral blood eosinophils in vitro.
    Solomon A; Shmilowich R; Shasha D; Frucht-Pery J; Pe'er J; Bonini S; Levi-Schaffer F
    Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1038-44. PubMed ID: 10752939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that the eosinophil is a cellular target for the inhibitory action of salmeterol on eosinophil recruitment in vivo.
    Teixeira MM; Hellewell PG
    Eur J Pharmacol; 1997 Apr; 323(2-3):255-60. PubMed ID: 9128847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adding salmeterol to an inhaled corticosteroid reduces allergen-induced serum IL-5 and peripheral blood eosinophils.
    Koopmans JG; Lutter R; Jansen HM; van der Zee JS
    J Allergy Clin Immunol; 2005 Nov; 116(5):1007-13. PubMed ID: 16275368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of receptor number on the stimulation by salmeterol of gene transcription in CHO-K1 cells transfected with the human beta2-adrenoceptor.
    McDonnell J; Latif ML; Rees ES; Bevan NJ; Hill SJ
    Br J Pharmacol; 1998 Oct; 125(4):717-26. PubMed ID: 9831907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The induction of eosinophil peroxidase release: improved methods of measurement and stimulation.
    Adamko DJ; Wu Y; Gleich GJ; Lacy P; Moqbel R
    J Immunol Methods; 2004 Aug; 291(1-2):101-8. PubMed ID: 15345309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of human eosinophil degranulation and activation by endogenous phospholipase A2.
    White SR; Strek ME; Kulp GV; Spaethe SM; Burch RA; Neeley SP; Leff AR
    J Clin Invest; 1993 May; 91(5):2118-25. PubMed ID: 8387540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.